Correlation Between Merck and Biophytis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Merck and Biophytis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Biophytis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and Biophytis, you can compare the effects of market volatilities on Merck and Biophytis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Biophytis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Biophytis.

Diversification Opportunities for Merck and Biophytis

0.9
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Merck and Biophytis is 0.9. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and Biophytis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biophytis and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with Biophytis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biophytis has no effect on the direction of Merck i.e., Merck and Biophytis go up and down completely randomly.

Pair Corralation between Merck and Biophytis

Considering the 90-day investment horizon Merck Company is expected to generate 0.17 times more return on investment than Biophytis. However, Merck Company is 6.0 times less risky than Biophytis. It trades about 0.0 of its potential returns per unit of risk. Biophytis is currently generating about -0.08 per unit of risk. If you would invest  10,449  in Merck Company on September 14, 2024 and sell it today you would lose (274.00) from holding Merck Company or give up 2.62% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy53.01%
ValuesDaily Returns

Merck Company  vs.  Biophytis

 Performance 
       Timeline  
Merck Company 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Biophytis 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biophytis has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Biophytis is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Merck and Biophytis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Merck and Biophytis

The main advantage of trading using opposite Merck and Biophytis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Biophytis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biophytis will offset losses from the drop in Biophytis' long position.
The idea behind Merck Company and Biophytis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Stocks Directory
Find actively traded stocks across global markets